Cancer Research PRL Inhibitor Induces the Cleavage of p130Cas  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 45, 5004-5010, October 1, 1985]
© 1985 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fellous, A.
Right arrow Articles by Smith, P. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fellous, A.
Right arrow Articles by Smith, P. T.

Effects of Tau and MAP2 on the Interaction of Maytansine with Tubulin: Inhibitory Effect of Maytansine on Vinblastine-Induced Aggregation of Tubulin1

A. Fellous2, R. F. Ludueña, V. Prasad, M. A. Jordan3, W. Anderson4, R. Ohayon2 and P. T. Smith

Department of Biochemistry, University of Texas Health Science Center, San Antonio, Texas 78284

Maytansine, a potent inhibitor of mitosis and in vitro microtubule assembly, was used to demonstrate a striking difference in the mechanism by which two of the main groups of brain microtubule-associated proteins, Tau and MAP2, interact with tubulin.

At the low concentrations of 0.5 to 2 µM, maytansine inhibited Tau-catalyzed tubulin assembly more effectively than it did MAP2-catalyzed assembly.

This effect differed markedly from that of vinblastine, although both drugs bind competitively to tubulin. At the same low con centrations, vinblastine almost completely inhibited Tau- and MAP2-mediated tubulin assembly.

At higher concentrations of 10 to 40 µM, a more striking difference was observed between the actions of the two drugs. Maytansine very effectively inhibited tubulin assembly promoted by either Tau or MAP2. Vinblastine also had this effect on MAP2-mediated tubulin assembly but in the presence of Tau induced extensive tubulin aggregation into spirals.

In addition maytansine strongly inhibited vinblastine-induced Tau-dependent tubulin aggregation into spiral polymers. Even at very low concentrations, maytansine completely inhibited the effect of very high concentrations of vinblastine.

These results very strongly suggest that the binding sites of maytansine and vinblastine on the tubulin molecule overlap and that the changes that they probably induce in the conformation of this molecule are markedly different, at least in the presence of microtubule-associated proteins.

1 This work was supported by Grant AQ726 from the Robert Welch Foundation and by Grant CA26376 from the NIH. Electron microscopy was supported by Grant NS13560 from the NIH to Dr. Leslie Wilson.

2 Present address: Unité Thyroide, INSERM, 94270 Bicêtre, France.

3 Present address: Department of Biological Sciences, University of California, Santa Barbara, CA 93206.

4 Present address: Department of Obstetric and Gynecology, University of Texas Health Science Center, San Antonio, TX 78294.

Received 4/ 6/84. Revised 3/20/85. Accepted 6/ 5/85.




This article has been cited by other articles:


Home page
J. Cell Sci.Home page
A Ploubidou, D. Robinson, R. Docherty, E. Ogbadoyi, and K Gull
Evidence for novel cell cycle checkpoints in trypanosomes: kinetoplast segregation and cytokinesis in the absence of mitosis
J. Cell Sci., January 12, 1999; 112(24): 4641 - 4650.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1985 by the American Association for Cancer Research.